Global Paediatric Orphan Drug Market Growth 2024-2030

2024

Global Paediatric Orphan Drug Market Growth 2024-2030

Name: Global Paediatric Orphan Drug Market Growth 2024-2030
Brand: Bonafide Research
SKU: 95001445
Price: 3450 USD
Availability: InStock
Rating: 5 (14.25 reviews)

The global pediatric orphan drug market is growing, fueled by the increasing need for treatments for rare pediatric diseases and disorders.

Bonafide Trust
14-08-2024
Pages : 123
Figures : 92
Tables : 142
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global paediatric orphan drug market is a rapidly growing sector within the pharmaceutical industry, driven by the increasing prevalence of rare pediatric diseases and the urgent need for effective treatments. This market encompasses a wide range of drugs designed to treat conditions such as pediatric cancers, genetic disorders, metabolic diseases, and rare infections. The rising awareness of rare pediatric diseases and the advocacy efforts by patient organizations have led to greater research and development in this field. Technological advancements in drug discovery and development are enabling the creation of targeted therapies that offer improved outcomes for young patients. The market is also benefiting from supportive regulatory frameworks and incentives for orphan drug development, encouraging pharmaceutical companies to invest in this area. The Asia-Pacific region is expected to be the fastest-growing market, driven by the increasing healthcare expenditure and the growing middle class. The global pediatric orphan drug market is projected to continue its upward trajectory, supported by ongoing research, innovation, and the introduction of new therapeutic options. This Insight Report provides a comprehensive analysis of the global Pediatric Orphan Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Orphan Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pediatric Orphan Drug market.

The global Pediatric Orphan Drug market size is projected to grow from US$ 75900 million in 2024 to US$ 150080 million in 2030; it is expected to grow at a CAGR of 12.0% from 2024 to 2030.
Publisher' newest research report, the “Pediatric Orphan Drug Industry Forecast” looks at past sales and reviews total world Pediatric Orphan Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Pediatric Orphan Drug sales for 2024 through 2030. With Pediatric Orphan Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Orphan Drug industry.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global pediatric orphan drug market is driven by several key factors, including the increasing prevalence of rare pediatric diseases, advancements in genetic research, supportive regulatory frameworks, and increased healthcare expenditure. Rare pediatric diseases, such as pediatric cancers, genetic disorders, and metabolic diseases, are becoming more recognized, leading to a higher demand for effective treatments. Advancements in genetic research and personalized medicine are enabling the development of targeted therapies that offer improved outcomes for young patients. Supportive regulatory frameworks, such as orphan drug designations and incentives, encourage pharmaceutical companies to invest in the development of treatments for rare pediatric conditions. Additionally, increased healthcare expenditure and growing awareness of rare pediatric diseases are driving market growth, particularly in regions with rising middle-class populations. These factors collectively contribute to the steady expansion of the global pediatric orphan drug market, making it a vital segment within the pharmaceutical industry.

The global pediatric orphan drug market is segmented by type into oncology drugs, genetic and metabolic disorders drugs, hematology drugs, infectious disease drugs, and others. Oncology drugs are designed to treat various types of pediatric cancers, offering targeted therapies that improve survival rates and reduce side effects. Genetic and Metabolic Disorders Drugs address rare genetic conditions and metabolic diseases, providing treatments that can significantly improve the quality of life for affected children. Hematology drugs focus on blood disorders, including hemophilia and sickle cell disease, offering therapies that help manage symptoms and prevent complications. Infectious Diseases Drugs target rare pediatric infections, providing effective treatments to combat these challenging conditions. The "others" category includes drugs for less common pediatric conditions and emerging therapies. Each type of drug plays a crucial role in addressing the specific needs of pediatric patients with rare diseases, driving innovation and growth in the global pediatric orphan drug market.

The global pediatric orphan drug market is segmented by application into pediatric oncology, genetic and metabolic disorders, hematology, infectious diseases, and others. Pediatric Oncology focuses on developing drugs to treat various types of cancers in children, offering targeted therapies that improve survival rates and reduce side effects. Genetic and metabolic disorders involve treatments for rare genetic conditions and metabolic diseases, providing therapies that significantly enhance the quality of life for affected children. Hematology addresses blood disorders such as hemophilia and sickle cell disease, offering treatments that help manage symptoms and prevent complications. Infectious diseases target rare pediatric infections, providing effective treatments to combat these challenging conditions. The "others" category includes drugs for less common pediatric conditions and emerging therapies. Each application segment addresses specific needs of pediatric patients with rare diseases, driving innovation and growth in the global pediatric orphan drug market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

The regional analysis of the global pediatric orphan drug market reveals distinct trends and growth patterns across different geographical areas. The North American region holds a dominant position, driven by a well-established healthcare infrastructure, high demand for advanced treatments, and significant government spending on healthcare. The region is home to leading pharmaceutical companies that frequently introduce new orphan drugs, ensuring patients have access to the latest options. Europe follows closely, with countries like Germany, the UK, and France leading in the adoption of innovative orphan drugs. The Asia-Pacific region is experiencing rapid growth, fueled by improving healthcare infrastructure, rising disposable incomes, and increasing awareness of rare pediatric diseases. Countries like China and India are major contributors to this growth, supported by local manufacturers and international players expanding their presence in these markets. The Latin American region is also witnessing steady growth, driven by improving healthcare systems and rising demand for orphan drugs. The Middle East and Africa regions are emerging markets, with increasing investments in healthcare infrastructure and a growing focus on improving the quality of care. Each region presents unique opportunities and challenges, with regional players adapting to local market conditions and regulatory environments to drive growth and innovation in the global pediatric orphan drug market.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediatric Orphan Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pediatric Orphan Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pediatric Orphan Drug by Country/Region, 2019, 2023 & 2030
2.2 Pediatric Orphan Drug Segment by Type
2.2.1 Oncology
2.2.2 Pulmonary
2.2.3 Neurology
2.2.4 Hematology
2.2.5 Endocrinology
2.2.6 Cardio-vascular
2.2.7 Metabolic Disorders
2.2.8 Others
2.3 Pediatric Orphan Drug Sales by Type
2.3.1 Global Pediatric Orphan Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Pediatric Orphan Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pediatric Orphan Drug Sale Price by Type (2019-2024)
2.4 Pediatric Orphan Drug Segment by Application
2.4.1 0-1 Years
2.4.2 1-3 Years
2.4.3 3-6 Years
2.4.4 6-12 Years
2.4.5 ? 12 Years
2.5 Pediatric Orphan Drug Sales by Application
2.5.1 Global Pediatric Orphan Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Pediatric Orphan Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pediatric Orphan Drug Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Pediatric Orphan Drug Breakdown Data by Company
3.1.1 Global Pediatric Orphan Drug Annual Sales by Company (2019-2024)
3.1.2 Global Pediatric Orphan Drug Sales Market Share by Company (2019-2024)
3.2 Global Pediatric Orphan Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Pediatric Orphan Drug Revenue by Company (2019-2024)
3.2.2 Global Pediatric Orphan Drug Revenue Market Share by Company (2019-2024)
3.3 Global Pediatric Orphan Drug Sale Price by Company
3.4 Key Manufacturers Pediatric Orphan Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Orphan Drug Product Location Distribution
3.4.2 Players Pediatric Orphan Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pediatric Orphan Drug by Geographic Region
4.1 World Historic Pediatric Orphan Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Pediatric Orphan Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pediatric Orphan Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pediatric Orphan Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Pediatric Orphan Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pediatric Orphan Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pediatric Orphan Drug Sales Growth
4.4 APAC Pediatric Orphan Drug Sales Growth
4.5 Europe Pediatric Orphan Drug Sales Growth
4.6 Middle East & Africa Pediatric Orphan Drug Sales Growth
5 Americas
5.1 Americas Pediatric Orphan Drug Sales by Country
5.1.1 Americas Pediatric Orphan Drug Sales by Country (2019-2024)
5.1.2 Americas Pediatric Orphan Drug Revenue by Country (2019-2024)
5.2 Americas Pediatric Orphan Drug Sales by Type (2019-2024)
5.3 Americas Pediatric Orphan Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Orphan Drug Sales by Region
6.1.1 APAC Pediatric Orphan Drug Sales by Region (2019-2024)
6.1.2 APAC Pediatric Orphan Drug Revenue by Region (2019-2024)
6.2 APAC Pediatric Orphan Drug Sales by Type (2019-2024)
6.3 APAC Pediatric Orphan Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pediatric Orphan Drug by Country
7.1.1 Europe Pediatric Orphan Drug Sales by Country (2019-2024)
7.1.2 Europe Pediatric Orphan Drug Revenue by Country (2019-2024)
7.2 Europe Pediatric Orphan Drug Sales by Type (2019-2024)
7.3 Europe Pediatric Orphan Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediatric Orphan Drug by Country
8.1.1 Middle East & Africa Pediatric Orphan Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pediatric Orphan Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Pediatric Orphan Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Pediatric Orphan Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Orphan Drug
10.3 Manufacturing Process Analysis of Pediatric Orphan Drug
10.4 Industry Chain Structure of Pediatric Orphan Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Orphan Drug Distributors
11.3 Pediatric Orphan Drug Customer
12 World Forecast Review for Pediatric Orphan Drug by Geographic Region
12.1 Global Pediatric Orphan Drug Market Size Forecast by Region
12.1.1 Global Pediatric Orphan Drug Forecast by Region (2025-2030)
12.1.2 Global Pediatric Orphan Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pediatric Orphan Drug Forecast by Type (2025-2030)
12.7 Global Pediatric Orphan Drug Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Pediatric Orphan Drug Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Pediatric Orphan Drug Product Portfolios and Specifications
13.2.3 Roche Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Pediatric Orphan Drug Product Portfolios and Specifications
13.3.3 Novartis Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Pediatric Orphan Drug Product Portfolios and Specifications
13.4.3 Johnson & Johnson Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Pediatric Orphan Drug Product Portfolios and Specifications
13.5.3 Pfizer Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Pediatric Orphan Drug Product Portfolios and Specifications
13.6.3 Amgen Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Pediatric Orphan Drug Product Portfolios and Specifications
13.7.3 Sanofi Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Pediatric Orphan Drug Product Portfolios and Specifications
13.8.3 AstraZeneca Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Takeda
13.9.1 Takeda Company Information
13.9.2 Takeda Pediatric Orphan Drug Product Portfolios and Specifications
13.9.3 Takeda Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Takeda Main Business Overview
13.9.5 Takeda Latest Developments
13.10 Vertex Pharmaceuticals
13.10.1 Vertex Pharmaceuticals Company Information
13.10.2 Vertex Pharmaceuticals Pediatric Orphan Drug Product Portfolios and Specifications
13.10.3 Vertex Pharmaceuticals Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vertex Pharmaceuticals Main Business Overview
13.10.5 Vertex Pharmaceuticals Latest Developments
13.11 AbbVie
13.11.1 AbbVie Company Information
13.11.2 AbbVie Pediatric Orphan Drug Product Portfolios and Specifications
13.11.3 AbbVie Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AbbVie Main Business Overview
13.11.5 AbbVie Latest Developments
13.12 Biogen
13.12.1 Biogen Company Information
13.12.2 Biogen Pediatric Orphan Drug Product Portfolios and Specifications
13.12.3 Biogen Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Biogen Main Business Overview
13.12.5 Biogen Latest Developments
13.13 Eli Lilly
13.13.1 Eli Lilly Company Information
13.13.2 Eli Lilly Pediatric Orphan Drug Product Portfolios and Specifications
13.13.3 Eli Lilly Pediatric Orphan Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Eli Lilly Main Business Overview
13.13.5 Eli Lilly Latest Developments
14 Research Findings and Conclusion

Table 1. Pediatric Orphan Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pediatric Orphan Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Oncology
Table 4. Major Players of Pulmonary
Table 5. Major Players of Neurology
Table 6. Major Players of Hematology
Table 7. Major Players of Endocrinology
Table 8. Major Players of Cardio-vascular
Table 9. Major Players of Metabolic Disorders
Table 10. Major Players of Others
Table 11. Global Pediatric Orphan Drug Sales by Type (2019-2024) & (Tons)
Table 12. Global Pediatric Orphan Drug Sales Market Share by Type (2019-2024)
Table 13. Global Pediatric Orphan Drug Revenue by Type (2019-2024) & ($ million)
Table 14. Global Pediatric Orphan Drug Revenue Market Share by Type (2019-2024)
Table 15. Global Pediatric Orphan Drug Sale Price by Type (2019-2024) & (US$/kg)
Table 16. Global Pediatric Orphan Drug Sale by Application (2019-2024) & (Tons)
Table 17. Global Pediatric Orphan Drug Sale Market Share by Application (2019-2024)
Table 18. Global Pediatric Orphan Drug Revenue by Application (2019-2024) & ($ million)
Table 19. Global Pediatric Orphan Drug Revenue Market Share by Application (2019-2024)
Table 20. Global Pediatric Orphan Drug Sale Price by Application (2019-2024) & (US$/kg)
Table 21. Global Pediatric Orphan Drug Sales by Company (2019-2024) & (Tons)
Table 22. Global Pediatric Orphan Drug Sales Market Share by Company (2019-2024)
Table 23. Global Pediatric Orphan Drug Revenue by Company (2019-2024) & ($ millions)
Table 24. Global Pediatric Orphan Drug Revenue Market Share by Company (2019-2024)
Table 25. Global Pediatric Orphan Drug Sale Price by Company (2019-2024) & (US$/kg)
Table 26. Key Manufacturers Pediatric Orphan Drug Producing Area Distribution and Sales Area
Table 27. Players Pediatric Orphan Drug Products Offered
Table 28. Pediatric Orphan Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 29. New Products and Potential Entrants
Table 30. Market M&A Activity & Strategy
Table 31. Global Pediatric Orphan Drug Sales by Geographic Region (2019-2024) & (Tons)
Table 32. Global Pediatric Orphan Drug Sales Market Share Geographic Region (2019-2024)
Table 33. Global Pediatric Orphan Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 34. Global Pediatric Orphan Drug Revenue Market Share by Geographic Region (2019-2024)
Table 35. Global Pediatric Orphan Drug Sales by Country/Region (2019-2024) & (Tons)
Table 36. Global Pediatric Orphan Drug Sales Market Share by Country/Region (2019-2024)
Table 37. Global Pediatric Orphan Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 38. Global Pediatric Orphan Drug Revenue Market Share by Country/Region (2019-2024)
Table 39. Americas Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)
Table 40. Americas Pediatric Orphan Drug Sales Market Share by Country (2019-2024)
Table 41. Americas Pediatric Orphan Drug Revenue by Country (2019-2024) & ($ millions)
Table 42. Americas Pediatric Orphan Drug Sales by Type (2019-2024) & (Tons)
Table 43. Americas Pediatric Orphan Drug Sales by Application (2019-2024) & (Tons)
Table 44. APAC Pediatric Orphan Drug Sales by Region (2019-2024) & (Tons)
Table 45. APAC Pediatric Orphan Drug Sales Market Share by Region (2019-2024)
Table 46. APAC Pediatric Orphan Drug Revenue by Region (2019-2024) & ($ millions)
Table 47. APAC Pediatric Orphan Drug Sales by Type (2019-2024) & (Tons)
Table 48. APAC Pediatric Orphan Drug Sales by Application (2019-2024) & (Tons)
Table 49. Europe Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)
Table 50. Europe Pediatric Orphan Drug Revenue by Country (2019-2024) & ($ millions)
Table 51. Europe Pediatric Orphan Drug Sales by Type (2019-2024) & (Tons)
Table 52. Europe Pediatric Orphan Drug Sales by Application (2019-2024) & (Tons)
Table 53. Middle East & Africa Pediatric Orphan Drug Sales by Country (2019-2024) & (Tons)
Table 54. Middle East & Africa Pediatric Orphan Drug Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Pediatric Orphan Drug Sales by Type (2019-2024) & (Tons)
Table 56. Middle East & Africa Pediatric Orphan Drug Sales by Application (2019-2024) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Pediatric Orphan Drug
Table 58. Key Market Challenges & Risks of Pediatric Orphan Drug
Table 59. Key Industry Trends of Pediatric Orphan Drug
Table 60. Pediatric Orphan Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pediatric Orphan Drug Distributors List
Table 63. Pediatric Orphan Drug Customer List
Table 64. Global Pediatric Orphan Drug Sales Forecast by Region (2025-2030) & (Tons)
Table 65. Global Pediatric Orphan Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Pediatric Orphan Drug Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Americas Pediatric Orphan Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Pediatric Orphan Drug Sales Forecast by Region (2025-2030) & (Tons)
Table 69. APAC Pediatric Orphan Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Pediatric Orphan Drug Sales Forecast by Country (2025-2030) & (Tons)
Table 71. Europe Pediatric Orphan Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Pediatric Orphan Drug Sales Forecast by Country (2025-2030) & (Tons)
Table 73. Middle East & Africa Pediatric Orphan Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Pediatric Orphan Drug Sales Forecast by Type (2025-2030) & (Tons)
Table 75. Global Pediatric Orphan Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 76. Global Pediatric Orphan Drug Sales Forecast by Application (2025-2030) & (Tons)
Table 77. Global Pediatric Orphan Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 78. Bristol-Myers Squibb Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Bristol-Myers Squibb Pediatric Orphan Drug Product Portfolios and Specifications
Table 80. Bristol-Myers Squibb Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 81. Bristol-Myers Squibb Main Business
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. Roche Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Pediatric Orphan Drug Product Portfolios and Specifications
Table 85. Roche Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Novartis Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Pediatric Orphan Drug Product Portfolios and Specifications
Table 90. Novartis Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Johnson & Johnson Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Pediatric Orphan Drug Product Portfolios and Specifications
Table 95. Johnson & Johnson Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Pfizer Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Pediatric Orphan Drug Product Portfolios and Specifications
Table 100. Pfizer Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Amgen Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Amgen Pediatric Orphan Drug Product Portfolios and Specifications
Table 105. Amgen Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 106. Amgen Main Business
Table 107. Amgen Latest Developments
Table 108. Sanofi Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Pediatric Orphan Drug Product Portfolios and Specifications
Table 110. Sanofi Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. AstraZeneca Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Pediatric Orphan Drug Product Portfolios and Specifications
Table 115. AstraZeneca Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Takeda Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Takeda Pediatric Orphan Drug Product Portfolios and Specifications
Table 120. Takeda Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 121. Takeda Main Business
Table 122. Takeda Latest Developments
Table 123. Vertex Pharmaceuticals Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Vertex Pharmaceuticals Pediatric Orphan Drug Product Portfolios and Specifications
Table 125. Vertex Pharmaceuticals Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 126. Vertex Pharmaceuticals Main Business
Table 127. Vertex Pharmaceuticals Latest Developments
Table 128. AbbVie Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. AbbVie Pediatric Orphan Drug Product Portfolios and Specifications
Table 130. AbbVie Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 131. AbbVie Main Business
Table 132. AbbVie Latest Developments
Table 133. Biogen Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Biogen Pediatric Orphan Drug Product Portfolios and Specifications
Table 135. Biogen Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 136. Biogen Main Business
Table 137. Biogen Latest Developments
Table 138. Eli Lilly Basic Information, Pediatric Orphan Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Eli Lilly Pediatric Orphan Drug Product Portfolios and Specifications
Table 140. Eli Lilly Pediatric Orphan Drug Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 141. Eli Lilly Main Business
Table 142. Eli Lilly Latest Developments

List of

Figure 1. Picture of Pediatric Orphan Drug
Figure 2. Pediatric Orphan Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Orphan Drug Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Pediatric Orphan Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Pediatric Orphan Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Pediatric Orphan Drug Sales Market Share by Country/Region (2023)
Figure 10. Pediatric Orphan Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Oncology
Figure 12. Product Picture of Pulmonary
Figure 13. Product Picture of Neurology
Figure 14. Product Picture of Hematology
Figure 15. Product Picture of Endocrinology
Figure 16. Product Picture of Cardio-vascular
Figure 17. Product Picture of Metabolic Disorders
Figure 18. Product Picture of Others
Figure 19. Global Pediatric Orphan Drug Sales Market Share by Type in 2023
Figure 20. Global Pediatric Orphan Drug Revenue Market Share by Type (2019-2024)
Figure 21. Pediatric Orphan Drug Consumed in 0-1 Years
Figure 22. Global Pediatric Orphan Drug Market: 0-1 Years (2019-2024) & (Tons)
Figure 23. Pediatric Orphan Drug Consumed in 1-3 Years
Figure 24. Global Pediatric Orphan Drug Market: 1-3 Years (2019-2024) & (Tons)
Figure 25. Pediatric Orphan Drug Consumed in 3-6 Years
Figure 26. Global Pediatric Orphan Drug Market: 3-6 Years (2019-2024) & (Tons)
Figure 27. Pediatric Orphan Drug Consumed in 6-12 Years
Figure 28. Global Pediatric Orphan Drug Market: 6-12 Years (2019-2024) & (Tons)
Figure 29. Pediatric Orphan Drug Consumed in ? 12 Years
Figure 30. Global Pediatric Orphan Drug Market: ? 12 Years (2019-2024) & (Tons)
Figure 31. Global Pediatric Orphan Drug Sale Market Share by Application (2023)
Figure 32. Global Pediatric Orphan Drug Revenue Market Share by Application in 2023
Figure 33. Pediatric Orphan Drug Sales by Company in 2023 (Tons)
Figure 34. Global Pediatric Orphan Drug Sales Market Share by Company in 2023
Figure 35. Pediatric Orphan Drug Revenue by Company in 2023 ($ millions)
Figure 36. Global Pediatric Orphan Drug Revenue Market Share by Company in 2023
Figure 37. Global Pediatric Orphan Drug Sales Market Share by Geographic Region (2019-2024)
Figure 38. Global Pediatric Orphan Drug Revenue Market Share by Geographic Region in 2023
Figure 39. Americas Pediatric Orphan Drug Sales 2019-2024 (Tons)
Figure 40. Americas Pediatric Orphan Drug Revenue 2019-2024 ($ millions)
Figure 41. APAC Pediatric Orphan Drug Sales 2019-2024 (Tons)
Figure 42. APAC Pediatric Orphan Drug Revenue 2019-2024 ($ millions)
Figure 43. Europe Pediatric Orphan Drug Sales 2019-2024 (Tons)
Figure 44. Europe Pediatric Orphan Drug Revenue 2019-2024 ($ millions)
Figure 45. Middle East & Africa Pediatric Orphan Drug Sales 2019-2024 (Tons)
Figure 46. Middle East & Africa Pediatric Orphan Drug Revenue 2019-2024 ($ millions)
Figure 47. Americas Pediatric Orphan Drug Sales Market Share by Country in 2023
Figure 48. Americas Pediatric Orphan Drug Revenue Market Share by Country (2019-2024)
Figure 49. Americas Pediatric Orphan Drug Sales Market Share by Type (2019-2024)
Figure 50. Americas Pediatric Orphan Drug Sales Market Share by Application (2019-2024)
Figure 51. United States Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 52. Canada Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 53. Mexico Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 54. Brazil Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 55. APAC Pediatric Orphan Drug Sales Market Share by Region in 2023
Figure 56. APAC Pediatric Orphan Drug Revenue Market Share by Region (2019-2024)
Figure 57. APAC Pediatric Orphan Drug Sales Market Share by Type (2019-2024)
Figure 58. APAC Pediatric Orphan Drug Sales Market Share by Application (2019-2024)
Figure 59. China Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. Japan Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. South Korea Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. Southeast Asia Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 63. India Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 64. Australia Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 65. China Taiwan Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 66. Europe Pediatric Orphan Drug Sales Market Share by Country in 2023
Figure 67. Europe Pediatric Orphan Drug Revenue Market Share by Country (2019-2024)
Figure 68. Europe Pediatric Orphan Drug Sales Market Share by Type (2019-2024)
Figure 69. Europe Pediatric Orphan Drug Sales Market Share by Application (2019-2024)
Figure 70. Germany Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. France Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 72. UK Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 73. Italy Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 74. Russia Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 75. Middle East & Africa Pediatric Orphan Drug Sales Market Share by Country (2019-2024)
Figure 76. Middle East & Africa Pediatric Orphan Drug Sales Market Share by Type (2019-2024)
Figure 77. Middle East & Africa Pediatric Orphan Drug Sales Market Share by Application (2019-2024)
Figure 78. Egypt Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 79. South Africa Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 80. Israel Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 81. Turkey Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 82. GCC Countries Pediatric Orphan Drug Revenue Growth 2019-2024 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Pediatric Orphan Drug in 2023
Figure 84. Manufacturing Process Analysis of Pediatric Orphan Drug
Figure 85. Industry Chain Structure of Pediatric Orphan Drug
Figure 86. Channels of Distribution
Figure 87. Global Pediatric Orphan Drug Sales Market Forecast by Region (2025-2030)
Figure 88. Global Pediatric Orphan Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 89. Global Pediatric Orphan Drug Sales Market Share Forecast by Type (2025-2030)
Figure 90. Global Pediatric Orphan Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 91. Global Pediatric Orphan Drug Sales Market Share Forecast by Application (2025-2030)
Figure 92. Global Pediatric Orphan Drug Revenue Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted